EUVIMEDEUVIMED entdecken
Crossref

“Identification of Malignancy Risk Factors in Endometrial Pathologies: The Role of Clinical, Laboratory Parameters, and Peripheral Blood Inflammatory Indices”

Hasan Altınsoy iD, Uğurcan Zorlu, Nisa Belemir Kırmacı, Yaprak Engin Üstün iD

American Journal of Reproductive Immunology · 2026

DOI: 10.1111/aji.70225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2026. Verfasst von Hasan Altınsoy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Perinatology, University of Health Sciences, Etlik Zübeyde Hanım Gynecology and Obstetrics Training and Research Hospital, Ankara, Turk…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Endometrium, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Postmenopausal bleeding (PMB) and increased endometrial thickness are key clinical indicators that may suggest underlying malignancies. While endometrial biopsy remains the diagnostic gold standard, its invasiveness underscores the need for alternative, noninvasive biomarkers. This study evaluates the potential of clinical, laboratory, and peripheral blood inflammatory indices (PBII) in distinguishing malignant from benign endometrial pathologies.

Methods

This retrospective study included 162 patients who underwent endometrial biopsy due to PMB and/or increased endometrial thickness between January 2023 and January 2024. Patients were categorized into benign ( n = 134) and malignant ( n = 28) groups. Demographic, clinical, and laboratory parameters were collected, PBII parameters were calculated, and comparisons were performed. Logistic regression analyses were conducted to identify independent predictors of malignancy.

Results

Malignant cases were significantly associated with older age ( p < 0.001), longer postmenopausal duration ( p = 0.002), higher body mass index (BMI) ( p = 0.018), and greater endometrial thickness ( p = 0.042) compared to benign cases. Hemoglobin levels were significantly lower ( p = 0.022), while neutrophil ( p < 0.001) and monocyte ( p = 0.042) counts were notably higher in malignant cases. Among PBII parameters, neutrophil‐to‐lymphocyte ratio (NLR), systemic immune‐inflammation index (SII), pan‐immune‐inflammation value (PIV), and systemic inflammation response index (SIRI) were significantly elevated ( p < 0.001 for all). Multivariate analysis identified older age ( p < 0.001), lower hemoglobin ( p = 0.016), higher neutrophil count ( p = 0.030), and increased PIV ( p = 0.022) as independent predictors of malignancy.

Conclusion

Integrating clinical and laboratory parameters with PBII, particularly PIV, may be a valuable, noninvasive tool for the early detection and risk stratification of endometrial malignancies. This approach could enhance diagnostic accuracy, reduce the need for invasive biopsies, and improve patient management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsEndometriumInflammationHumansFemaleMiddle AgedRetrospective StudiesRisk FactorsNeutrophilsPostmenopauseAgedBiopsyAdultUterine Hemorrhage

Stichwörter der Autor:innen

delta neutrophil indexendometrial malignancyendometrial thicknessmalignancy risk stratificationperipheral blood inflammatory indicespostmenopausal bleeding

Autor:innen und Institutionen

  • Department of Perinatology, University of Health Sciences, Etlik Zübeyde Hanım Gynecology and Obstetrics Training and Research Hospital, Ankara, Turkey.
  • Department of Perinatology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey.
  • Department of Obstetrics and Gynecology, University of Health Sciences, Etlik Zübeyde Hanım Gynecology and Obstetrics Training and Research Hospital, Ankara, Turkey.

ORCID-Profile: Hasan Altınsoy, Yaprak Engin Üstün

Zitieren

APA

Altınsoy, H., Zorlu, U., Kırmacı, N. B., & Üstün, Y. E. (2026). “Identification of Malignancy Risk Factors in Endometrial Pathologies: The Role of Clinical, Laboratory Parameters, and Peripheral Blood Inflammatory Indices”. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70225

Vancouver

Altınsoy H, Zorlu U, Kırmacı NB, Üstün YE. “Identification of Malignancy Risk Factors in Endometrial Pathologies: The Role of Clinical, Laboratory Parameters, and Peripheral Blood Inflammatory Indices”. American Journal of Reproductive Immunology. 2026. doi:10.1111/aji.70225

BibTeX
@article{Altnsoy2026,
  author = {Altınsoy, Hasan and Zorlu, Uğurcan and Kırmacı, Nisa Belemir and Üstün, Yaprak Engin},
  title = {“Identification of Malignancy Risk Factors in Endometrial Pathologies: The Role of Clinical, Laboratory Parameters, and Peripheral Blood Inflammatory Indices”},
  journal = {American Journal of Reproductive Immunology},
  year = {2026},
  doi = {10.1111/aji.70225}
}
Kostenlos starten →